Efficacy of Anti-tumor Synergistic Formula Combined with Tegafur on Advanced Colorectal Cancer and Effect on Quality of Life and Serum Tumor Markers

GONG Qing-hao; DAI Gang; CHEN Hai-qun; FEI Zhe-wei; CAI Yi-ting

doi:10.13422/j.cnki.syfjx.2017110171

您当前的位置：

首页 >

文章列表页 >

Efficacy of Anti-tumor Synergistic Formula Combined with Tegafur on Advanced Colorectal Cancer and Effect on Quality of Life and Serum Tumor Markers

更新时间：2024-01-04

- Efficacy of Anti-tumor Synergistic Formula Combined with Tegafur on Advanced Colorectal Cancer and Effect on Quality of Life and Serum Tumor Markers
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 23, Issue 11, Pages: 171-176(2017)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2017110171
  CLC： R735.34
- Published：2017
- 稿件说明：
移动端阅览
GONG Qing-hao, DAI Gang, CHEN Hai-qun, et al. Efficacy of Anti-tumor Synergistic Formula Combined with Tegafur on Advanced Colorectal Cancer and Effect on Quality of Life and Serum Tumor Markers[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(11): 171-176.
DOI：

GONG Qing-hao, DAI Gang, CHEN Hai-qun, et al. Efficacy of Anti-tumor Synergistic Formula Combined with Tegafur on Advanced Colorectal Cancer and Effect on Quality of Life and Serum Tumor Markers[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(11): 171-176. DOI： 10.13422/j.cnki.syfjx.2017110171.

摘要

目的：观察抗瘤增效方联合替吉奥治疗晚期结直肠癌疗效及对生存质量、血清肿瘤标志物的影响，并探讨其作用机制。方法：选取2013年1月至2015年12月确诊的100例晚期结直肠癌（advanced colorectal cancer，ACC）患者，随机分成两组，每组50例。对照组予替吉奥胶囊治疗，研究组在上述基础上予抗瘤增效方治疗。检测外周血T淋巴细胞和相关肿瘤标志物，评估生活质量，随访并记录各自生存时间，比较治疗效果和生存率。结果：与治疗前比较，对照组CD3+，CD4+，CD4+/CD8+降低（P<0.01），CD8+升高（P<0.01）；研究组CD3+，CD4+，CD4+/CD8+升高（P<0.01），CD8+降低（P<0.01）；两组癌胚抗原（carcinoembryonic antigen，CEA），肿瘤相关黏液抗原（carbohydrate antigen 242，CA242），糖链抗原19-9（carbohydrate antigen 19-9，CA19-9）均显著降低（P<0.01），生活质量核心量表（Quality of Life Questionnaire-Core 30，QLQ-C30）功能领域评分升高（P< 0.01），QLQ-C30症状领域评分降低（P< 0.01）；治疗后与对照组比较，研究组CD3+，CD4+，CD4+/CD8+较高（P<0.01），CD8+较低（P< 0.01），CEA，CA242，CA19-9较低（P<0.01）；QLQ-C30功能领域评分较高（P<0.01），QLQ-C30症状领域评分较低（P<0.01），客观缓解率（objective response rate，ORR）较高（P<0.05），随访生存率较高（P<0.05）。结论：抗瘤增效方联合替吉奥能提高ACC生存质量和生存率，治疗效果较理想，值得借鉴。

Abstract

Objective: To investigate the efficacy of anti-tumor synergistic formula combined with tegafur on advanced colorectal cancer and the effect on quality of life and serum tumor markers

and explore their mechanism of action. Method: A total of 100 advanced colorectal cancer (ACC) patients diagnosed at our hospital between January 2013 and December 2015 were selected and randomly divided into two groups

with 50 cases in each group. The control group was treated with Gimeracil and Oteracil Porassium capsules

and the experiment group was treated with anti-tumor synergistic formula in addition to the therapy of control group. Peripheral blood T lymphocytes and related tumor markers were detected

the quality of life was assessed

and follow-up visits were made to record their respective survival time and compare the treatment effect and survival rate. Result: Compared with before treatment

CD3+

CD4+ and CD4+/CD8+ levels were lower (P<0.01)

and the CD8+ level was higher (P<0.01) in control group

and the CD3+

CD4+ and CD4+/CD8+ levels were higher (P<0.01)

and the CD8+ level was lower (P<0.01) in experiment group. Carcinoembryonic antigen (CEA)

carbohydrate antigen 242 (CA242) and carbohydrate antigen 19-9 (CA19-9) levels were lower in two groups (P<0.01)

the Quality of Life Questionnaire-Core 30 (QLQ-C30) scale function domain score was increased (P<0.01)

and the QLQ-C30 symptom domain score was lower (P<0.01). Compared with control group

the CD3+

CD4+ and CD4+/CD8+ levels were higher (P<0.01)

the CEA

CA242 and CA19-9 levels were lower (P<0.01)

the QLQ-C30 scale function domain score was increased (P<0.01)

and the QLQ-C30 symptom domain score was lower (P<0.01)

the objective response rate (ORR) was higher (P<0.05)

and the follow-up survival rate was higher (P<0.05) in experiment group. Conclusion: Anti-tumor synergistic formula combined with tegafur can improve the quality of life and survival of ACC

shows an ideal treatment effect

and is worth promotion.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Prevention and Treatment of Colorectal Cancer Through Traditional Chinese Medicine Targeted Wnt Signaling Pathway： A Review

Regulation of Ferroptosis by Traditional Chinese Medicine for Colorectal Cancer Intervention： A Review

Efficacy Mechanism of Xianlian Jiedu Prescription Against Colorectal Cancer Recurrence vias Regulating Angiogenesis

Traditional Chinese Medicine Regulates JAK/STAT Signaling Pathway to Treat Colorectal Cancer： A Review

Invasion and Metastasis in Colorectal Cancer Mediated by Traditional Chinese Medicine via Cell Signaling Pathway： A Review

Related Author

SHEN Jialin

ZHAO Xiaoying

XUE Chengcheng

LYU Yi

SHI Shang

MA Yuyuan

ZHOU Cheng

YANG Lin

Related Institution

Shuguang Hospital Affiliated to Shanghai University of TCM

Xianyang Central Hospital

Changzhou Hospital of Traditional Chinese Medicine（TCM）

The Affiliated Hospital of Shaanxi University of Chinese Medicine

Shaanxi University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰